Dr. Reddy's Infringes Cancer Med Patents, Allos Says
Allos Therapeutics Inc. has recently hit Dr. Reddy's Laboratories Ltd. with a lawsuit in New Jersey federal court to halt the production of a generic form of cancer treatment drug Folotyn,...To view the full article, register now.
Already a subscriber? Click here to view full article